Development of Fragment-Specific Osteopontin Antibodies and ELISA for Quantification in Human Metastatic Breast Cancer

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-8-38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2006English

Competitive ELISA Employing Monoclonal Antibodies Specific for Coronafacoyl Amino Acid Conjugates

Food and Agricultural Immunology
ImmunologyAgronomyCrop ScienceFood Science
1997English

Association of Osteopontin Promoter Polymorphism and Aggresivness in Breast Cancer

Sohag Medical Journal
2018English

Assay of Matrix Metalloproteases Types 8 and 9 by ELISA in Human Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1995English

ELISA for the Detection of Specific IgM and IgG in Human Leptospirosis

Microbiology
Microbiology
1985English

Precision Medicine for Metastatic Breast Cancer

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2015English

Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Stem Cells in Human Breast Development and Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Choosing Treatment for Metastatic Breast Cancer.

BMJ
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy